Drug class
Adenosine Triphosphate-Citrate Lyase Inhibitor; Dietary Cholesterol Absorption Inhibitor; Decreased Cholesterol Absorption
Mechanism of action
Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]
General use cases
- Hyperlipoproteinemia Type II
- Atherosclerosis
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
